Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
09/27/2001 | WO2001070932A2 Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife |
09/27/2001 | WO2001070931A2 A mammalian oocyte-specific linker histone gene h1oo |
09/27/2001 | WO2001070930A2 Growth factor binding molecules |
09/27/2001 | WO2001070929A2 Transgenic plants containing heat shock protein |
09/27/2001 | WO2001070816A2 Ecdysone receptor-based inducible gene expression system |
09/27/2001 | WO2001070815A1 Novel leukotriene b4 receptor |
09/27/2001 | WO2001070814A2 Regulation of human rta-like g protein-coupled receptor |
09/27/2001 | WO2001070813A2 REGULATION OF HUMAN GluR5-LIKE RECEPTOR |
09/27/2001 | WO2001070812A2 Regulation of human histamine h2-like g protein-coupled receptor |
09/27/2001 | WO2001070811A1 Potassium channel protein kcnq5, a target for diseases of central nervous system and cardiovascular system |
09/27/2001 | WO2001070810A2 Atp binding cassette transporter 1 (abc1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases |
09/27/2001 | WO2001070809A1 A novel polypeptide - protein 9 of growth hormone-family and a polynucleotide sequence encoding the same |
09/27/2001 | WO2001070808A2 Angiogenesis - associated proteins, and nucleic acids encoding the same |
09/27/2001 | WO2001070807A2 G-protein associated molecules |
09/27/2001 | WO2001070806A2 Human secreted proteins and polynucleotides encoding the same |
09/27/2001 | WO2001070805A2 Soluble mast cell function associated antigen (mafa) pharmaceutical compositions and methods of making and using them |
09/27/2001 | WO2001070804A1 7 human ovarian and ovarian cancer associated proteins |
09/27/2001 | WO2001070803A1 A novel polypeptide - human regulatory transcription factor 9.7 and a polynucleotide sequence encoding the same |
09/27/2001 | WO2001070802A1 A novel polypeptide, zinc finger protein 11 and the polynucleotide encoding thereof |
09/27/2001 | WO2001070799A1 Novel protein having hemolytic activity and gene encoding the protein |
09/27/2001 | WO2001070798A2 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
09/27/2001 | WO2001070797A1 Ligand-controlled anion channels of insects |
09/27/2001 | WO2001070796A1 A novel polypeptide, a human zinc finger protein 78 and the polynucleotide encoding the polypeptide |
09/27/2001 | WO2001070794A1 A novel polypeptide, a human zinc finger protein 11 and the polynucleotide encoding the polypeptide |
09/27/2001 | WO2001070793A1 A novel polypeptide, a human mitochondrial carrier protein 9 and the polynucleotide encoding the polypeptide |
09/27/2001 | WO2001070791A1 A novel polypeptide, a human nf-e2 relative factor 14 and the polynucleotide encoding the polypeptide |
09/27/2001 | WO2001070789A1 A novel polypeptide-human ribosomal protein s5-17 and the polynucleotide encoding said polypeptide |
09/27/2001 | WO2001070786A1 A novel polypeptide, a human tnfr/ngfr protein containing cytochrome c domain and the polynucleotide encoding the polypeptide |
09/27/2001 | WO2001070784A1 A novel polypeptide-human protein 17 containing chromo domain and the polynucleotide encoding said polypeptide |
09/27/2001 | WO2001070783A1 A novel polypeptide-human gamma-cop protein 16 and the polynucleoide encoding said polypeptide |
09/27/2001 | WO2001070781A1 A novel polypeptide-human ilf 13 and the polynucleotide encoding said polypeptide |
09/27/2001 | WO2001070780A1 A novel polypeptide-human ribosomal sii protein 12 and the polynucleotide encoding said polypeptide |
09/27/2001 | WO2001070779A1 A novel polypeptide-human cdc4 analogous protein and the polynucleotide encoding said polypeptide |
09/27/2001 | WO2001070778A2 Maize glycine rich protein promoter and use thereof |
09/27/2001 | WO2001070777A2 Leafy cotyledon2 genes and their uses |
09/27/2001 | WO2001070776A2 Nimr compositions and their methods of use |
09/27/2001 | WO2001070775A2 Wnt-1 related polypeptides, and nucleic acids encoding the same |
09/27/2001 | WO2001070774A2 Human t cell response to mhc-binding motif clusters |
09/27/2001 | WO2001070773A2 Insecticidal peptides and methods for using same |
09/27/2001 | WO2001070771A2 Acute neuronal induced calcium binding protein type 1 ligand |
09/27/2001 | WO2001070769A1 Peptide derivative |
09/27/2001 | WO2001070768A2 Receptor-binding compounds and method for identifying them |
09/27/2001 | WO2001070767A2 Therapeutic anti-melanoma compounds |
09/27/2001 | WO2001070766A2 Therapeutic anti-cytomegalovirus compounds |
09/27/2001 | WO2001070765A1 Receptor-binding compounds and methods for identifying them |
09/27/2001 | WO2001070764A2 Epitopes of mycobacterium tuberculosis secreted antigens and uses thereof |
09/27/2001 | WO2001070763A1 Modified blood clotting factors and methods of use |
09/27/2001 | WO2001070762A2 Adsorption of polyampholytes to charged surfaces and assays incorporating same |
09/27/2001 | WO2001070759A1 Potassium channel kcnq5 |
09/27/2001 | WO2001070730A1 Method of producing 6-substituted (s)-nicotine derivatives and intermediate compounds |
09/27/2001 | WO2001070685A2 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
09/27/2001 | WO2001070261A1 Sperm factor oscillogenin |
09/27/2001 | WO2001070257A1 Chimeric nontoxic mutants of enterotoxins as mucosal adjuvants for cell-mediated or humoral immunity |
09/27/2001 | WO2001070254A1 Use of human not1 and not1a orphan receptors |
09/27/2001 | WO2001070253A1 Use of mia in immunotherapy |
09/27/2001 | WO2001070252A1 Novel borrelia burgdorferi polypeptides and uses thereof |
09/27/2001 | WO2001070247A2 Salmonella vaccine materials and methods |
09/27/2001 | WO2001070245A1 Immune mediators and related methods |
09/27/2001 | WO2001070244A1 Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses |
09/27/2001 | WO2001070174A2 Vegf-modulated genes and methods employing them |
09/27/2001 | WO2001070173A2 Immunokine composition and method |
09/27/2001 | WO2001032856A3 Seed-preferred promoter from barley |
09/27/2001 | WO2001032833A3 Monalisa, a g-protein coupled receptor |
09/27/2001 | WO2001025421B1 Materials and method for detecting interaction of cftr polypeptides |
09/27/2001 | WO2001021802B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
09/27/2001 | WO2001020020A3 Method to identify herbicides, fungicides or plant growth regulators |
09/27/2001 | WO2001019990B1 Rip-3-like death-associated kinase |
09/27/2001 | WO2001019973A3 Nicotinic acetylcholine receptor: alpha10 subunit |
09/27/2001 | WO2001018546A3 Screening for inhibitors of 'paired helical filaments' |
09/27/2001 | WO2001018056A3 Method of gene therapy for improving the efficiency of cancer therapy |
09/27/2001 | WO2001018030A3 Small peptides having potent anti-angiogenic activity |
09/27/2001 | WO2001017558A3 Novel uses of mammalian ccr6 receptors and related reagents |
09/27/2001 | WO2001016176A3 Transgenic animal model for neurodegenerative diseases |
09/27/2001 | WO2001016170A3 Card proteins involved in cell death regulation |
09/27/2001 | WO2001012127B1 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
09/27/2001 | WO2001010903A3 Proteases and protease inhibitors |
09/27/2001 | WO2001009178A3 Human chaperone proteins |
09/27/2001 | WO2001007588A3 Dna sequences which code nodulation factors |
09/27/2001 | WO2001006910A3 VARIATION IN DRUG RESPONSE RELATED TO POLYMORPHISMS IN β2- ADRENERGIC RECEPTOR |
09/27/2001 | WO2001002430A3 Arabidopsis thaliana cdc7 and cdc27 homologs |
09/27/2001 | US20010025380 Family of maize PR-1 genes and promoters |
09/27/2001 | US20010025379 Transgenic plant |
09/27/2001 | US20010025100 Translation initiation factor 4AIII, and methods of use thereof |
09/27/2001 | US20010025099 G protein-coupled receptor polypeptides and polyncleotides |
09/27/2001 | US20010025098 Polynucleotides; genetic engineering |
09/27/2001 | US20010025097 Somatostatins and methods |
09/27/2001 | US20010025037 Introducing a patient in need of insulin into the lower respiratory tract an effective amount of active compounds in the form of powder containing insulin and bile salt which enhance the absorption of insulin in the lungs of patient |
09/27/2001 | US20010025031 HFGAN72 receptor genomic DNA, variants thereof, and methods of use thereof in diagnostic applications |
09/27/2001 | US20010025026 Chimeric proteins for use in transport of a selected substance into cells |
09/27/2001 | US20010025022 Hnovilr |
09/27/2001 | US20010024817 Viral nucleotide sequences |
09/27/2001 | US20010024813 Human dendriac and brainiac-3 |
09/27/2001 | US20010024808 Leptin induced genes |
09/27/2001 | US20010024782 Procaryotic cells containing a diverse population of expressible oligonucleotides operationally linked to expression elements, the oligonucleotides having a desirable bias of random codon sequences; kits |
09/27/2001 | US20010024652 An isolated nucleic acid molecule which encodes a T-cell derived inducible factor (TIFS), the complementary sequence of which hybridizes, under stringent conditions, to a specific nucleotide sequence |
09/27/2001 | US20010024650 Artery - and vein-specific proteins and uses therefor |
09/27/2001 | US20010024648 Four monkey monoclonal antibodies 7B6, 16C10, 7C10 and 20C9 which inhibit the B7:CD28 pathway and thereby function as effeftive immunosuppressants for the treatment of autoimmune diseases and prevent organ trasplant rejection |
09/27/2001 | DE10015413A1 Composition for treating and diagnosing viral infections, caused by adenovirus, comprises an agent that modifies function of YB-1 protein, and YB-1 specific antibodies |
09/27/2001 | DE10013847A1 Parallel detection of methylation in genomic DNA where DNA is chemically modified, fragmented, amplified and hybridized to probes, useful to investigate gene expression regulation |
09/27/2001 | DE10013732A1 New DNA sequence encoding potassium channel KCNQ5, useful in screening for specific modulators, potential agents for treating central nervous system and cardiovascular diseases |